Interaction between bradykinin and urodilatin - a possible mechanism of clinical relevance

IF 2.9 3区医学 Q2 Medicine

BMC Pharmacology & Toxicology Pub Date : 2011-08-01 DOI:10.1186/1471-2210-11-S1-P21

Marina Dobrivojević, Aleksandra Sinđić, Bojana Nikitović, B. Edemir, E. Schlatter, W. Forssmann, J. Hirsch

引用次数: 0

查看原文本刊更多论文

缓激肽和尿扩张素的相互作用——一种可能的临床相关性机制

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Pharmacology & Toxicology PHARMACOLOGY & PHARMACY-TOXICOLOGY

CiteScore

4.40

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.